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ICommentary I
Immunological Reflections on Asbestos
by Robert Burrell*
As a pulmonary immunologist interest in
all forms of immune injury to the lung, I have
had some experience with related minerals,
such as silica and coal mine dust.
When compared to the immunologic aspects
of silicosis or coal workers' pneumonitis (CWP),
the bulk of the immunologic evidence concer-
ning asbestosis is scanty and unimpressive. To
begin with, most of the experimental work is
irrelevant because it dealt with doses that were
much too high. Moreover, infected rats were
often the experimental animals, there were no
attempts to distinguish effects caused by
asbestos from those caused by the almost
universal opportunistic infections by myco-
plasmas, and finally too much of the work
used irrelevant experimental procedures like in-
jecting the asbestos fibers into some organ or
lumen.
Aside from this we can ask a few questions,
speculate a little, suggest a few avenues of ap-
proach, award some bouquets, and cast a few
stones. The pleural plaques contain collagen and
I would expect that there would be im-
munofluorescent localization of globulin at
these sites, but Zaidi (1) and Turner-Warwick
(2) in separte studies on limited material did not
find such. Do these people produce antilungcon-
nective tissue antibodies seen in other chronic
pulmonary disease? Turner-Warwick has found
them, but was unimpressed with the frequency
in the small population ofcases she has studied.
Similarly, since IgA is known to be greatly in-
creased in miners with CWP, could one look for
IgA levels in patients with asbestosis? Turner-
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Warwick (2) again has followed this lead and in-
deed finds this to be the case in a smaller
proportion than seen in CWP.
Several authors (3-5) have reported in-
creased rheumatoid factor (RF) and antinuclear
factor (ANA) in CWP, while Turner-Warwick
(6) has looked for these in asbestosis cases. She
finds fourfold increases in prevalence (when
compared with a normal population) and
suggests that since some people show a
predisposition to form such autoantibodies and
since the occurrence of ANA reactivity especial-
ly is related to radiographic extentofasbestosis,
then routine screening for ANA in asbestos
workers would be agood epidemiological tool, in
that positive reactors should be discouraged
from working in jobs where they would be ex-
posed to the asbestos dusts. Pernis et al. (7)
could not in one brief experiment induce RF ex-
perimentally with asbestos.
I urge great caution to those interested in
looking for serum antibodies in pulmonary or
intestinal exposure to environmental agents
because these organs have a different im-
munologic system, i.e., the secretory system,
than that found in the peripheral blood and is
not necessarily reflected in the serum. I would
suggest that investigators employ bronchial or
intestinal secretions for a better picture of any
immunologic response to such agents.
Perhaps a too obvious possibility, but is that
naked asbestos fiber antigenic itself? My in-
stincts would say no because silica is not, but
then my instincts would have predicted that
beryllium was not a good antigen either, and
there is conclusive evidence that it is (8). It is ob-
vious that the fiber can be coated with various
types of innate proteins and possibly microbial
December 1974 297products. I suggest that in this manner asbestos
could function as an antigenic carrier or even as
an adjuvant as in the case of silica. I am un-
aware of any investigation along these lines.
There is a report from England (unpublished)
that mesothelioma tumor fluid is cytotoxic for
cultured mesothelioma cells but not other cell
cultures. Thus it seems to have immunologic
specificity, and I find this an exciting finding. I
do not believe this is any of the lymphokines
because such substances would be cytotoxic for
other cell cultures.
Information about cell-associated immunity
(in contrast to the serum or humoral associated
immunity) appears to be stronger. On the
negative side, since the hyperkeratosis
associated with dermally imbedded fibers dis-
appears when the foreign body is removed, it
suggests that there is no delayed hypersensitivi-
ty as in berylliosis. This may in turn be related
to solubility, but I am told that asbestos fibers
are indeed soluble in vivo.
Lymphocytes are seen infiltrating
mesotheliomas and to an immunologist, such
cells always suggest a cell associated immune
response. Turner-Warwick has found (2) that
PHA stimulation was imparied in 4 of 12
asbestosis patients. Such a test is regarded as a
good way to determine T cell function in an
animal, and those with immunologic deficiency
syndromes of T cell origin show similar results.
This suggests that, as with any tumor,
mesotheliomas develop in people who develop
immunologic abnormalities. For these reasons I
suggest that any epidemiologic study of
asbestos workers include tests for both T and B
cell competence as a measure of their immune
competence. The British have recognized this
possibility and are proceeding ahead.
Turner-Warwick has a small bit of evidence
that asbestos may be antigenic in stimulating
cell-mediated immunity, as she has been able to
demonstrate inhibition of macrophages in some
asbestos workers when appropriate cells are in-
cubated with asbestos fibers. This is a currently
respectable technique for assessing cell-
mediated respones immunologically.
In addition, let me say to those who made
such statements as "you are studying it to
death", "it's a human disease so let's study
humans", or "John-Manville can't employ
pathogen-free workers, so what good are
pathogen-free animals?", I hope this sort of
thinking isn't prevalent. Had it been in the past,
we would have never had vaccines, antibiotics,
renal dialysis, or ball and socket prosthesis. We
study asbestosis because, even if we eliminated
all environmental exposure today, we would still
be seeing asbestosis well into the next century.
If we understand how it happens, maybe we can
do something about it. As an experimentalist
there is a great deal that can be done in the
laboratory that is directly applicable to the
human situation ifthe experiments are designed
properly. Indeed, all of my studies are with the
human in mind. I must stress the use of
pathogen free animals, especially if one is using
rats. The evidence is abundant that
Mycoplasmas and other opportunistic rodent in-
fections can cause significant changes in
animals, and the experimentalist by definition
must isolate one phenomenon for critical review
at a time so that he may determine exactly the
individual contribution of the variable he is
measuring. I would suggest that (1) pathogen-
free animals are being used, (2) that they are
kept that way by strict quarantine measures,
and (3) that the animals are constantly
monitored for Mycoplasma infection. Similarly,
since cell culture utilizing macrophages and
fibroblasts will be becoming more important for
study of in vitro effects of asbestos and silica, I
suggest that in order to be believed, all ex-
perimental protocols include monitoring of the
cultures for Mycoplkma.
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